yes, we all thought EPT are raising extra money to bring melanotan to market 100% themselves with no big pharma.
unfortunately in the open briefing, its not true, epitan said they are looking to bring melanotan to market in europe and USA with a PARTNER, so that means EPT will not get 100% of profit on sales, but only say 15% of sales if it goes in with a JV partner, like they intend too.
melanotan, page-3
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.73 |
Change
0.120(0.88%) |
Mkt cap ! $687.3M | |||
| Open | High | Low | Value | Volume |
| $13.55 | $13.90 | $13.54 | $835.5K | 61.00K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 312 | $13.68 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.76 | 226 | 1 |
View Market Depth
| Last trade - 16.10pm 05/11/2024 (20 minute delay) ? |
| CUV (ASX) Chart |